Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia

by | Apr 17, 2018 | Globe Newswire

Suppression of both BCl-2 and Mcl-1 anti-apoptotic proteins is a novel strategy in CLL 

Suppression of both BCl-2 and Mcl-1 anti-apoptotic proteins is a novel strategy in CLL